Your search returned 91 studies. (Get alerts for new studies):
- A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheuma
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: Huntsville, Alabama
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Huntsville, Alabama
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Fayetteville, Tennessee
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Huntsville, Alabama
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Tullahoma, Tennessee
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Huntsville, Alabama
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Huntsville, Alabama
- Prospective Observational Epidemiologic Study of Maraviroc's Safety
Conditions: Human Immunodeficiency Virus
Location: Huntsville, Alabama
- AngelMed for Early Recognition and Treatment of STEMI
Conditions: Acute Myocardial Infarction (AMI) - Coronary Occlusion - Acute Coronary Syndrome
Location: Huntsville, Alabama
- Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
Conditions: Type 2 Diabetes Mellitus
Location: Huntsville, Alabama
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Huntsville, Alabama
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Murfreesboro, Tennessee
- Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Conditions: Benign Prostatic Hyperplasia
Location: Huntsville, Alabama
- Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic FOLFOX6
Conditions: Colon Cancer With Metastases to the Liver
Location: Huntsville, Alabama
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Tullahoma, Tennessee
- AIGISRx Envelope for Prevention of Infection Following Replacement With a Cardiac Resynchronization Therapy Device (CRT)
Conditions: Cardiac Rhythm Management Device Infection
Location: Decatur, Alabama
- AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Conditions: Implantable Cardioverter-Defibrillator Infection
Location: Decatur, Alabama
- Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing E
Conditions: Acute Coronary Syndrome
Location: Huntsville, Alabama
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: Huntsville, Alabama
- Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-
Conditions: Squamous Cell Lung Cancer
Location: Huntsville, Alabama
- Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodg
Conditions: Indolent Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma
Location: Huntsville, Alabama
- An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Conditions: Chronic Lymphocytic Leukemia - Lymphoma, Non-Hodgkin - Acute Myeloid Leukemia - Multiple Myeloma
Location: Huntsville, Alabama
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Conditions: Diarrhea Predominant Irritable Bowel Syndrome
Location: Athens, Alabama
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Conditions: Diarrhea Predominant Irritable Bowel Syndrome
Location: Huntsville, Alabama
- Efficacy and Safety of Abatacept Subcutaneous (SC) in Combination With Methotrexate in Adults With Very Early Rheumatoid Arthritis (RA)
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Huntsville, Alabama
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Toney, Alabama
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Lawrenceburg, Tennessee
- A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Acti
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)
Conditions: Early Rheumatoid Arthritis
Location: Huntsville, Alabama
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Huntsville, Alabama
- A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
Conditions: Acute Coronary Syndrome
Location: Huntsville, Alabama
- A Study in Patients With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
Conditions: Arthritis, Rheumatoid
Location: Huntsville, Alabama
- An Open Label Study for Patients With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- POMx In the Treatment of Erectile Dysfunction
Conditions: Erectile Dysfunction
Location: Huntsville, Alabama
- A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Conditions: Coronary Heart Disease, Graft Occlusion, Vascular
Location: Huntsville, Alabama
- Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Conditions: Colorectal Neoplasms - Digestive System Diseases - Colonic Diseases - Colorectal Cancer
Location: Huntsville, Alabama
- Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
Conditions: Indolent Non-Hodgkin Lymphoma - Follicular Lymphoma - Small Lymphocytic Lymphoma - Lymphoplasmacytoid Lymphoma - Marginal Zone Lymphoma
Location: Huntsville, Alabama
- A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Ar
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Conditions: Cervical Dystonia - Blepharospasm
Location: Columbia, Tennessee
- Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hosp
Conditions: Heart Failure
Location: Tullahoma, Tennessee
- A Study of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GALTON)
Conditions: Chronic Lymphocytic Leukemia
Location: Huntsville, Alabama
- A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Conditions: Overactive Bladder
Location: Huntsville, Alabama
- A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Conditions: Overactive Bladder
Location: Scottsboro, Alabama
- Maximum Tolerated Dose Study of Belinostat (PXD-101)in Combination With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Stage IV Non-S
Conditions: Stage IV Non-small Cell Lung Cancer
Location: Huntsville, Alabama
- A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention
Conditions: Myocardial Infarction
Location: Huntsville, Alabama
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Athens, Alabama
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Huntsville, Alabama
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Tullahoma, Tennessee
- DeNovo NT Longitudinal Data Collection (LDC) Knee Study
Conditions: Degenerative Lesion of Articular Cartilage of Knee - Osteochondritis Dissecans
Location: Huntsville, Alabama
- A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Conditions: Cardiovascular Disease, Rheumatoid Arthritis
Location: Huntsville, Alabama
- A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Sin
Conditions: Coronary Artery Disease (CAD)
Location: Huntsville, Alabama
- Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobul
Conditions: B Cell Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Waldenstrom Macroglobulinemia
Location: Huntsville, Alabama
- Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe
Conditions: Low Back Pain
Location: Huntsville, Alabama
- The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel
Conditions: Acute Coronary Syndrome
Location: Huntsville, Alabama
- Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Conditions: Colorectal Lesions
Location: Huntsville, Alabama
- Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- Allopurinol Outcome Study
Conditions: Gout
Location: Huntsville, Alabama
- Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
Conditions: Lung Resection - Open Thoracotomy
Location: Birmingham, Alabama
- ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Conditions: Coronary Artery Disease
Location: Huntsville, Alabama
- Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
Conditions: Low Back Pain
Location: Huntsville, Alabama
- The Jetstream (JET) Post-market Registry
Conditions: Peripheral Arterial Diseases
Location: Huntsville, Alabama
- Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chro
Conditions: Chronic Obstructive Pulmonary Disease
Location: Athens, Alabama
- Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chro
Conditions: Chronic Obstructive Pulmonary Disease
Location: Scottsboro, Alabama
- Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chro
Conditions: Chronic Obstructive Pulmonary Disease
Location: Fayetteville, Tennessee
- Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Conditions: Benign Prostatic Hyperplasia
Location: Huntsville, Alabama
- Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Conditions: Coronary Artery Disease - Angina Pectoris
Location: Huntsville, Alabama
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Athens, Alabama
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Fayetteville, Tennessee
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Shelbyville, Tennessee
- Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism
Conditions: Male Hypogonadism
Location: Huntsville, Alabama
- Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis
Conditions: Gastroparesis - Diabetes Mellitus, Type 1 - Diabetes Mellitus, Type 2
Location: Huntsville, Alabama
- Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Pati
Conditions: Arrhythmias, Cardiac - Heart Diseases - Cardiovascular Diseases - Implantable Cardioverter Defibrillator
Location: Huntsville, Alabama
- Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Conditions: Chronic Gout
Location: Huntsville, Alabama
- Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment
Conditions: Heart Failure - Cardiac Failure - Acute Decompensated Heart Failure (ADHF)
Location: Huntsville, Alabama
- A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)
Conditions: Type 2 Diabetes Mellitus
Location: Huntsville, Alabama
- A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Conditions: Irritable Bowel Syndrome
Location: Huntsville, Alabama
- AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction
Conditions: ST Segment Elevation Myocardial Infarction
Location: Huntsville, Alabama
- Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Conditions: Diabetic Peripheral Neuropathy
Location: Huntsville, Alabama
- A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients Wi
Conditions: Non-Small Cell Lung Cancer
Location: Huntsville, Alabama
- Riata® Lead Evaluation Post Market Study
Conditions: Incidence of Externalized Cables in Riata Leads
Location: Huntsville, Alabama
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Fayetteville, Tennessee
- A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovasc
Conditions: Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Location: Huntsville, Alabama
- A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer
Location: Huntsville, Alabama
- A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (
Conditions: Chronic Lymphocytic Leukemia
Location: Huntsville, Alabama
- Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Conditions: Diabetic Neuropathy, Painful
Location: Tullahoma, Tennessee
|